ARSPHARMA
Board
1 directorMandates through the years
1 name, the dashed line is todayControl
100%
This company
ARSPHARMA
Equity €197,851
Profit €28,113 in 2025
Capital
- Contribution
- €6,300
- Shares
- 186
- Contribution per share
- €33.87
- Equity per share
- €1,064 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- MDC-INTERIEUR
- REMEDIA
- GLOBAL PHARMA GROUP
Source: lists of holdings in the owners' accounts
Shareholders
2 ownersOwners 2
- MDC-INTERIEURparentEquity €338,629 Profit of €26,082 in 2025 (profit of €34,080 in 2024) Checked score 96100%
- REMEDIAparentEquity €1.4m Profit of €14,913 in 2025 (profit of €644,028 in 2024)Sourceaccounts REMEDIA 2025100%